 |
Case Report
Salvage chemotherapy with 5-fluorouracil and actinomycin D for advanced testicular germ cell tumor: A case with elevated human chorionic gonadotropin
1 Department of Urology, Niigata Prefectural Central Hospital, 205 Shinnancho, Joetsu City, Niigata Prefecture 943-0192, Japan
Address correspondence to:
Tatsuro Sanami
MD, 205 Shinnancho, Joetsu City, Niigata Prefecture 943-0192,
Japan
Message to Corresponding Author
Article ID: 101490Z01TS2025
Access full text article on other devices
Access PDF of article on other devices
How to cite this article
Sanami T, Katagiri A, Arinami K, Watanabe K, Inui K, Yamaguchi S. Salvage chemotherapy with 5-fluorouracil and actinomycin D for advanced testicular germ cell tumor: A case with elevated human chorionic gonadotropin. Int J Case Rep Images 2025;16(1):11–15.ABSTRACT
Introduction: Platinum-based chemotherapy is the standard treatment for advanced testicular germ cell tumors. However, selecting third-line and further regimens is difficult in refractory cases. We report a case of testicular mixed germ cell tumor treated with a salvage regimen for high-risk gestational trophoblastic tumor.
Case Report: A 48-year-old male was diagnosed with an advanced mixed germ cell tumor of the right testis with markedly elevated human chorionic gonadotropin levels. Induction and second-line chemotherapy with platinum-based regimens did not achieve normalization of the tumor marker. As salvage chemotherapy, a regimen of 5-fluorouracil and actinomycin D was applied, which led to remission of the tumor marker. However, additional consolidation courses were discontinued due to cumulative adverse events and the patient’s wishes. Ultimately the patient died of tumor recurrence.
Conclusion: We report the first case of testicular germ cell tumor in which a regimen of 5-fluorouracil and actinomycin D showed effectiveness. This regimen for high-risk gestational trophoblastic tumor is also considered a promising treatment option for testicular germ cell tumors with a choriocarcinoma element.
Keywords: Choriocarcinoma, FA, Human chorionic gonadotropin, Testicular tumor
SUPPORTING INFORMATION
Author Contributions
Tatsuro Sanami - Substantial contributions to conception and design, Acquisition of data, Analysis of data, Interpretation of data, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published
Akiyoshi Katagiri - Acquisition of data, Interpretation of data, Drafting the article, Final approval of the version to be published
Kentaro Arinami - Acquisition of data, Interpretation of data, Drafting the article, Final approval of the version to be published
Kazuhiro Watanabe - Acquisition of data, Interpretation of data, Drafting the article, Final approval of the version to be published
Kohei Inui - Acquisition of data, Interpretation of data, Drafting the article, Final approval of the version to be published
Shunsuke Yamaguchi - Interpretation of data, Drafting the article, Final approval of the version to be published
Guarantor of SubmissionThe corresponding author is the guarantor of submission.
Source of SupportNone
Consent StatementWritten informed consent was obtained from the patient for publication of this article.
Data AvailabilityAll relevant data are within the paper and its Supporting Information files.
Conflict of InterestAuthors declare no conflict of interest.
Copyright© 2025 Tatsuro Sanami et al. This article is distributed under the terms of Creative Commons Attribution License which permits unrestricted use, distribution and reproduction in any medium provided the original author(s) and original publisher are properly credited. Please see the copyright policy on the journal website for more information.
